Cyclerion Therapeutics, Inc. Contracts & Agreements

40 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment #1 to License Agreement by and between the Company and Akebia Therapeutics, Inc. dated December 13, 2024
License Agreements
Cyclerion Therapeutics, Inc.
2024
Amendment to Original Offer Letter Regina Graul
Cyclerion Therapeutics, Inc.
2024
Amended and Restated Recognition Bonus Agreement, dated December 21, 2022, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino
Bonus & Incentive Agreements
Cyclerion Therapeutics, Inc.
2024
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
2024
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino
Cyclerion Therapeutics, Inc.
2024
Amended and Restated Recognition Bonus Agreement, dated December 21, 2022, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault
Bonus & Incentive Agreements
Cyclerion Therapeutics, Inc.
2024
Offer Letter to Regina Graul dated December 1, 2023
Cyclerion Therapeutics, Inc.
2024
Consulting Agreement with Peter Hecht dated December 1, 2023
Consulting Agreements
Cyclerion Therapeutics, Inc.
2024
Restricted Stock Agreement with Regina Graul dated December 1, 2023
Stock Agreements
Cyclerion Therapeutics, Inc.
2024
Restricted Stock Agreement with Peter Hecht dated December 1, 2023
Stock Agreements
Cyclerion Therapeutics, Inc.
2024
Restricted Stock Agreement with Regina Graul dated January 1, 2024
Stock Agreements
Cyclerion Therapeutics, Inc.
2024
Restricted Stock Agreement with Peter Hecht dated January 1, 2024
Stock Agreements
Cyclerion Therapeutics, Inc.
2024
Separation and Release of Claims Agreement, dated October 17, 2023, by and between Cyclerion Therapeutics, Inc. and Anjeza Gjino
Separation Agreements
Cyclerion Therapeutics, Inc.
2023
Separation Agreement, effective June 26, 2023, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault
Separation Agreements
Cyclerion Therapeutics, Inc.
2023
Form of Voting and Support Agreement
Voting Agreements
Cyclerion Therapeutics, Inc.
2023
Asset Purchase Agreement, dated as of May 11, 2023, among the Company, JW Celtics Investment Corp. and JW Cycle Inc
Purchase Agreements
Cyclerion Therapeutics, Inc.
2023
Cyclerion Therapeutics, Inc. Executive Severance Plan
Severance Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
2022
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Cheryl Gault
Cyclerion Therapeutics, Inc.
2022
Non-Employee Director Compensation Plan (amended and restated as of December 17, 2021)
Compensation Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
2022
Employment Agreement, effective April 29, 2019, by and between Cyclerion GmbH and Andreas Busch
Employment Agreements
Cyclerion Therapeutics, Inc.
2022
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
2022
Lease Termination Agreement, dated as of April 30, 2021, by and between BMR-Rogers Street LLC and the Company
Lease Agreements
Cyclerion Therapeutics, Inc.
2021
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
Biotechnology
2021
Open Market Sale AgreementSM, dated September 3, 2020, by and between Cyclerion Therapeutics, Inc. and Jefferies LLC
Cyclerion Therapeutics, Inc.
2020
Common Stock Purchase Agreement dated as of July 29, 2020, by and between Cyelerion Therapeuties, Inc. and he Investors Named Therein
Stock Agreements
Cyclerion Therapeutics, Inc.
2020
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Cyclerion Therapeutics, Inc.
2020
First Amendment to and Partial Termination of Lease Agreement Lease, dated April 1, 2019, by and between BMR-Rogers Street LLC and the Company
Lease Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
2020
Cyclerion Therapeutics, Inc. Executive Severance Plan
Severance Agreements
Cyclerion Therapeutics, Inc.
2019
Non-Employee Director Compensation Plan (effective June 1, 2019)
Compensation Agreements
Cyclerion Therapeutics, Inc.
2019
Separation Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Separation Agreements
Cyclerion Therapeutics, Inc.
2019
Lease, dated April 1, 2019, by and between BMR-Rogers Street LLC and Cyclerion Therapeutics, Inc
Lease Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
CA
2019
Transition Services Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Transition Agreements
Cyclerion Therapeutics, Inc.
2019
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and William Huyett
Cyclerion Therapeutics, Inc.
2019
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Mark G. Currie, Ph.D
Cyclerion Therapeutics, Inc.
2019
Offer Letter, effective April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Peter M. Hecht, Ph.D
Cyclerion Therapeutics, Inc.
Biotechnology
2019
Intellectual Property License Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
License Agreements
Cyclerion Therapeutics, Inc.
2019
Development Agreement, dated as of April 1, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Development Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
MA
2019
Employee Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Cyclerion Therapeutics, Inc.
Biotechnology
MA
2019
Tax Matters Agreement, dated as of March 30, 2019, by and between Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc
Cyclerion Therapeutics, Inc.
2019
Transition Services Agreement, dated as of April 1, 2019, by and between Cyclerion Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc
Transition Agreements
Cyclerion Therapeutics, Inc.
Biotechnology
DE
2019